Fangfang Xie

Fangfang Xie


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2025 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
BBBihui Bai
Bihui Bai
XXXingwen Xie
Xingwen Xie
YYYongyu Yue
Yongyu Yue
JCJiahe Cui
Jiahe Cui
FXFangfang Xie
Fangfang Xie
FYFei Yao
Fei Yao
Objective: Plenty of evidence proves the prospective diagnostic and prognostic utility of inflammatory markers in osteoporosis (OP). However, the relations of immune-inflammatory indices to OP remain elusive, with scarce conclusive evidence-based findings. Our systematic review and meta-analysis endeavored to unveil the links between immune-inflammatory indices and OP. Methods: PubMed, Web of Science, Embase, as well as Cochrane Library, were thoroughly retrieved for research investigating the links of immune-inflammatory indices to OP, from database inception to February 20, 2025. Data were analyzed using odds ratio (OR), standardized mean difference (SMD), as well as corresponding 95% confidence interval (CI). Sensitivity and subgroup analyses were carried out for result robustness evaluation and heterogeneity source identification. Review Manager 5.4 and STATA 18.0 were utilized in every statistical analysis. Results: A total of 24 studies were included in this analysis. Eight cohort studies and 16 case–control studies based on 397,525 subjects and 11,904 cases were eventually screened and retained. The findings indicated significant positive relations of immune-inflammatory indices to OP risk. For categorical variables, elevated neutrophil-to-lymphocyte ratio (NLR) (OR = 2.34, 95% CI 1.77–3.11; P < 0.00001), platelet-to-lymphocyte ratio (PLR) (OR = 1.05, 95% CI 1.01–1.08; P = 0.01), as well as systemic immune-inflammation index (SII) (OR = 1.16, 95% CI 1.04–1.30; P = 0.01) notably correlated with a increased OP risk. For continuous variables, individuals with OP exhibited significantly higher levels of NLR (SMD = 0.71, 95% CI 0.35–1.07; P = 0.0001), PLR (SMD = 0.43, 95% CI 0.17–0.68; P = 0.001), monocyte-to-lymphocyte ratio (MLR) (SMD = 0.54, 95% CI 0.16–0.91; P = 0.005), and SII (SMD = 0.25, 95% CI 0.03–0.47; P = 0.03) compared to non-OP populations. Subgroup analyses revealed that geographic region and age were major contributing factors influencing the association between immune-inflammatory indices and OP. Conclusion: Immune-inflammatory indices such as NLR, PLR, MLR, and SII are significantly linked to increased risk of OP. These indices may facilitate the early identification of individuals at high risk for OP and support timely preventive strategies. Given the inherent limitations of the current study, further prospective, multicenter clinical investigations are warranted to validate the relations of immune-inflammatory indices to OP. Trial registration Systematic review registration: PROSPERO, identifier: CRD420250656296.

3 September 2021 in Trials
Verified
Journal Article
Open access
PDF file
ZCZiji Cheng
Ziji Cheng
ZCZiying Chen
Ziying Chen
FXFangfang Xie
Fangfang Xie
CGChong Guan
Chong Guan
YGYuanjia Gu
Yuanjia Gu
FYFei Yao
Fei Yao
Background: Non-specific chronic neck pain (NCNP) is a common musculoskeletal disorder which has caused a huge economic burden due to its expensive health costs and high re-occurrence rate. Yijinjing and Tuina are widely used for non-specific chronic neck pain in China. But there is little scientific evidence to evaluate their efficacy for NCNP. The aim of this research is to compare the efficacy of Yijinjng combined with Tuina versus Tuina for patients with NCNP. Methods/design: A randomized controlled trial in which 102 patients with non-specific chronic neck pain will be recruited and randomly allocated to either the Tuina group or the Yijinjng combined with Tuina group in a 1:1 ratio. The interventions for both groups will be carried out three times a week for 8 weeks. The patients in the two groups will receive follow-up 1 month after the intervention. The primary outcome will be the changes in the visual analog scale (VAS). Secondary outcomes will be measured by the Neck Disability Index (NDI), Self-Rating Anxiety Scale (SAS), and Tissue Hardness and Active Range of Motion (AROM). The data will be analyzed at the baseline, 4 weeks during the intervention, at the end of the intervention, and 1 month after the intervention. The significance level sets as 5%. The safety of interventions will be evaluated after each treatment session. Discussion: The purpose of this trial is to determine whether Yijinjing combined with Tuina is not inferior to Tuina for patients with NCNP. This study will provide clinicians and stakeholders much-needed knowledge for a complementary and alternative therapy for patients with non-specific chronic neck pain. Trial registration: ChiCTR registry (ChiCTR) 2000036805. Registered on August 25, 2020

20 July 2023 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
HYHongyu Yue
Hongyu Yue
YLYang Li
Yang Li
JMJianwen Ma
Jianwen Ma
CXChaoqun Xie
Chaoqun Xie
FXFangfang Xie
Fangfang Xie
FYFei Yao
Fei Yao
Background: Knee osteoarthritis (KOA) is a common public health problem and a leading cause of long-term pain, decreased muscle strength, and even disability. Tai Chi has been proved effective and highly recommended for KOA management worldwide. However, little is known about its benefits on quadriceps strength which is closely associated with relieving knee pain. This trial is designed to evaluate the efficacy and safety of Tai Chi on knee pain and muscle strength in middle-aged and older adults with KOA. Methods: A total of 100 participants will be randomly divided into a Tai Chi group (TC group) (1x/week for 12 weeks) and a control group with a health education and stretching program (1x/week for 12 weeks) with a follow-up period of 6 weeks. The primary outcome is the change of Western Ontario and McMaster Universities (WOMAC) pain subscale at week 12 compared with baseline. Secondary outcomes include WOMAC stiffness and function subscales, data from isokinetic dynamometry, gait analysis with electromyography (EMG), and a 36-item short form health survey (SF-36). The daily dose of pain-relieving medication will also be recorded. All adverse effects will be assessed by the Treatment Emergent Symptom Scale (TESS). Discussion: We expect this randomized trial to evaluate the effectiveness of Tai Chi on relieving pain and increasing quadriceps strength in KOA patients. This protocol, if proven effective, will contribute to providing a promising alternative intervention for middle-aged and older adults with KOA. Trials registration number: This trial has been registered in the China Clinical Trials Registry (registration number: ChiCTR2300069339).

7 August 2026 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
JCJuntao Chen
Juntao Chen
JCJiahe Cui
Jiahe Cui
HHHaotian Han
Haotian Han
FXFangfang Xie
Fangfang Xie
FYFei Yao
Fei Yao
To examine the association between insomnia symptom severity and emotion regulation difficulties and identify potential moderators. This was a cross-sectio